← Back to headlines
Seres Therapeutics Reports Q4 GAAP EPS of $0.64, Revenue of $0.78M
Seres Therapeutics announced its GAAP earnings per share for the latest quarter was $0.64, with total revenue reaching $0.78 million.
12 Mar, 19:38 — 12 Mar, 19:38
Sources
Showing 1 of 1 sources
